Table 3.
CD14 genotype distribution in the Dutch Caucasian subfertility cohort.
CD14 -260 C>T | |||||||
1.1 (CC) | 1.2 (CT) | 2.2 (TT) | |||||
Total | n | % | n | % | n | % | |
Total | 253 | 70 | 27,7% | 124 | 49,0% | 59 | 23,3% |
TP+ | 50 | 14 | 28,0% | 24 | 48,0% | 12 | 24,0% |
TP- | 203 | 56 | 27,6% | 100 | 49,3% | 47 | 23,2% |
CT IgG+ TP+ | 28 | 9 | 32,1% | 15 | 53,6% | 4 | 14,3% |
CT IgG+ TP- | 13 | 4 | 30,8% | 6 | 46,2% | 3 | 23,1% |
Healthy Controls | 170 | 48 | 28,2% | 82 | 48,2% | 40 | 23,5% |
Distribution in the total cohort and subdivided in women with or without tubal pathology, and C. trachomatis IgG positive women with or without tubal pathology. C. trachomatis positivity defined as a titre ≥ 1:32 (MIF). Abbreviations: TP: tubal pathology; CT: Chlamydia trachomatis.